EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients

Lee S Gottesdiener, Michael J Satlin iD

Transplant Infectious Disease · 2023-11 · 25 (S1)

DOI: 10.1111/tid.14169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, online erschienen am 20.10.2023. Verfasst von Lee S Gottesdiener und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are at high risk of developing bacterial infections. These patients may suffer severe consequences from these infections if they do not receive immediate effective therapies, and thus are uniquely threatened by antimicrobial‐resistant bacteria. Here, we outline how the emergence of specific resistant bacteria threatens the effectiveness of established approaches to prevent and treat infections in this population. The emergence of fluoroquinolone resistance among Enterobacterales and viridans group streptococci may decrease the effectiveness of fluoroquinolone prophylaxis during neutropenia. The emergence of Enterobacterales that produce extended‐spectrum β‐lactamases or carbapenemases and of increasingly resistant Pseudomonas aeruginosa may result in neutropenic patients experiencing delayed time to active antibacterial therapy, and consequently worse clinical outcomes. The ability to select targeted antibacterial therapies after the availability of susceptibility data may be limited in patients infected with metallo‐β‐lactamase‐producing Enterobacterales and difficult‐to‐treat P. aeruginosa . Vancomycin‐resistant enterococci and Stenotrophomonas maltophilia can cause breakthrough infections in patients already being treated with broad‐spectrum β‐lactam antibiotics. Resistance can also limit the ability to provide oral stepdown antibacterial therapy for patients who could otherwise be discharged from hospitalization. We also outline strategies that have the potential to mitigate the negative impact of antimicrobial resistance, including interventions based on active screening for colonization with resistant bacteria and the use of novel rapid diagnostic assays. Additional research is needed to better understand how these strategies can be leveraged to combat the emerging crisis of antimicrobial resistance in patients with hematologic malignancies and HCT recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHematologic NeoplasmsHumansTransplant RecipientsAnti-Bacterial AgentsFluoroquinolonesPseudomonas aeruginosaMicrobial Sensitivity Tests

Stichwörter der Autor:innen

EnterobacteralesPseudomonas aeruginosaStenotrophomonas maltophiliaantimicrobial resistancehematologic malignancyhematopoietic cell transplantationvancomycin-resistant enterococci

Substanzen

Anti-Bacterial AgentsFluoroquinolones

Autor:innen und Institutionen

  • Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
  • NewYork-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York, USA.
  • Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Michael J Satlin

Förderung

  • NIAID NIH HHS

Zitieren

APA

Gottesdiener, L. S., & Satlin, M. J. (2023). Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients. Transplant Infectious Disease, 25(S1). https://doi.org/10.1111/tid.14169

Vancouver

Gottesdiener LS, Satlin MJ. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients. Transplant Infectious Disease. 2023;25(S1). doi:10.1111/tid.14169

BibTeX
@article{Gottesdiener2023,
  author = {Gottesdiener, Lee S and Satlin, Michael J},
  title = {Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients},
  journal = {Transplant Infectious Disease},
  year = {2023},
  volume = {25},
  number = {S1},
  doi = {10.1111/tid.14169}
}
Kostenlos starten →